- Home
- ZKIN vs EPIX Comparison
ZKIN vs EPIX Comparison
Compare ZKIN & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKIN
- EPIX
- Stock Information
- Founded
- ZKIN 2015
- EPIX 2009
- Country
- ZKIN China
- EPIX Canada
- Employees
- ZKIN N/A
- EPIX N/A
- Industry
- ZKIN Metal Fabrications
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- ZKIN Industrials
- EPIX Health Care
- Exchange
- ZKIN Nasdaq
- EPIX Nasdaq
- Market Cap
- ZKIN 9.9M
- EPIX 9.1M
- IPO Year
- ZKIN 2017
- EPIX N/A
- Fundamental
- Price
- ZKIN $2.17
- EPIX $0.20
- Analyst Decision
- ZKIN
- EPIX Hold
- Analyst Count
- ZKIN 0
- EPIX 3
- Target Price
- ZKIN N/A
- EPIX $2.00
- AVG Volume (30 Days)
- ZKIN 160.5K
- EPIX 15.7M
- Earning Date
- ZKIN 01-27-2026
- EPIX 08-13-2025
- Dividend Yield
- ZKIN N/A
- EPIX N/A
- EPS Growth
- ZKIN N/A
- EPIX N/A
- EPS
- ZKIN N/A
- EPIX N/A
- Revenue
- ZKIN $108,199,877.00
- EPIX N/A
- Revenue This Year
- ZKIN N/A
- EPIX N/A
- Revenue Next Year
- ZKIN N/A
- EPIX N/A
- P/E Ratio
- ZKIN N/A
- EPIX N/A
- Revenue Growth
- ZKIN N/A
- EPIX N/A
- 52 Week Low
- ZKIN $0.82
- EPIX $0.19
- 52 Week High
- ZKIN $6.30
- EPIX $7.41
- Technical
- Relative Strength Index (RSI)
- ZKIN 51.90
- EPIX 7.66
- Support Level
- ZKIN $1.80
- EPIX $0.19
- Resistance Level
- ZKIN $2.65
- EPIX $0.21
- Average True Range (ATR)
- ZKIN 0.28
- EPIX 0.02
- MACD
- ZKIN 0.05
- EPIX 0.02
- Stochastic Oscillator
- ZKIN 30.42
- EPIX 24.25
About ZKIN ZK International Group Co. Ltd
ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.